A BILL 
To amend title XVIII of the Social Security Act to provide 
coverage under the Medicare program for FDA-approved 
qualifying colorectal cancer screening blood-based tests, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Donald Payne Sr. 
4
Colorectal Cancer Detection Act of 2019’’. 
5
02:31 Mar 29, 2019
H1765
2 
•HR 1765 IH
SEC. 2. MEDICARE COVERAGE FOR FDA-APPROVED QUALI-
1
FYING 
COLORECTAL 
CANCER 
SCREENING 
2
BLOOD-BASED TESTS. 
3
(a) IN GENERAL.—Section 1861(pp) of the Social Se-
4
curity Act (42 U.S.C. 1395x(pp)) is amended— 
5
(1) in paragraph (1)— 
6
(A) by redesignating subparagraph (D) as 
7
subparagraph (E); and 
8
(B) by inserting after subparagraph (C) 
9
the following new subparagraph: 
10
‘‘(D) Qualifying colorectal cancer screening 
11
blood-based test.’’; and 
12
(2) by adding at the end the following new 
13
paragraph: 
14
‘‘(3) The term ‘qualifying colorectal cancer screening 
15
blood-based test’ means, with respect to a year, a screen-
16
ing blood-based test for the early detection of colorectal 
17
cancer furnished in the year that was marketed or used, 
18
as applicable, in accordance with the relevant provisions 
19
of section 353 of the Public Health Service Act or the 
20
Federal Food, Drug, and Cosmetic Act more than 6 
21
months before the beginning of the year.’’. 
22
(b) FREQUENCY LIMITS FOR COLORECTAL CANCER 
23
SCREENING TESTS AND PAYMENT AMOUNT FOR QUALI-
24
FYING COLORECTAL CANCER SCREENING BLOOD-BASED 
25
02:31 Mar 29, 2019
H1765
3 
•HR 1765 IH
TESTS.—Section 1834(d) of the Social Security Act (42 
1
U.S.C. 1395m(d)) is amended— 
2
(1) by amending clause (ii) of paragraph (1)(B) 
3
to read as follows: 
4
‘‘(ii) if the test is performed within— 
5
‘‘(I) the 11 months after a pre-
6
vious screening fecal-occult blood test 
7
or a previous qualifying colorectal 
8
cancer screening blood-based test; 
9
‘‘(II) the 35 months after a pre-
10
vious screening flexible sigmoidoscopy 
11
or a previous screening colonoscopy 
12
with adenoma findings; 
13
‘‘(III) the 59 months after a pre-
14
vious screening colonoscopy with small 
15
polyp findings; or 
16
‘‘(IV) the 119 months after a 
17
previous screening colonoscopy with-
18
out adenoma findings or small polyp 
19
findings.’’; 
20
(2) in paragraph (2)(E)(ii), by inserting ‘‘or 
21
within the 35 months after a previous screening 
22
fecal-occult 
blood 
test 
or 
previous 
qualifying 
23
colorectal cancer screening blood-based test’’ after 
24
‘‘sigmoidoscopy’’; 
25
02:31 Mar 29, 2019
H1765
4 
•HR 1765 IH
(3) by amending subparagraph (E) of para-
1
graph (3) to read as follows: 
2
‘‘(E) FREQUENCY
LIMIT.—No payment 
3
may be made under this part for a colorectal 
4
cancer screening test consisting of a screening 
5
colonoscopy— 
6
‘‘(i) if the procedure is performed 
7
within the 11 months after a previous 
8
screening fecal-occult blood test or previous 
9
qualifying 
colorectal 
cancer 
screening 
10
blood-based test; 
11
‘‘(ii) for individuals at high risk for 
12
colorectal cancer if the procedure is per-
13
formed within the 23 months after a pre-
14
vious screening colonoscopy; or 
15
‘‘(iii) for individuals not at high risk 
16
for colorectal cancer if the procedure is 
17
performed within the 119 months after a 
18
previous screening colonoscopy or within 
19
the 47 months after a previous screening 
20
flexible sigmoidoscopy.’’; and 
21
(4) by adding at the end the following new 
22
paragraph: 
23
‘‘(4) 
QUALIFYING
COLORECTAL
CANCER 
24
SCREENING BLOOD-BASED TESTS.— 
25
02:31 Mar 29, 2019
H1765
5 
•HR 1765 IH
‘‘(A) PAYMENT
AMOUNT.—The payment 
1
amount for colorectal cancer screening tests 
2
consisting of qualifying colorectal cancer screen-
3
ing blood-based tests shall be established by the 
4
Secretary. 
5
‘‘(B) 
FREQUENCY
LIMIT.—Paragraph 
6
(1)(B) shall apply to colorectal cancer screening 
7
tests consisting of qualifying colorectal cancer 
8
screening blood-based tests in the same manner 
9
as such paragraph applies to colorectal cancer 
10
screening tests consisting of fecal-occult blood 
11
tests.’’. 
12
(c) EFFECTIVE DATE.—The amendments made by 
13
this section shall apply to colorectal cancer screening tests 
14
furnished in a year beginning more than 6 months after 
15
the date of the enactment of this Act. 
16
Æ 
02:31 Mar 29, 2019
H1765
